Eli Lilly (LLY) Change in Acquisitions & Divestments (2009 - 2025)

Eli Lilly (LLY) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $132.0 million the latest figure, recorded in Q4 2025.

• Change in Acquisitions & Divestments for Q4 2025 came in at $132.0 million, up 135.71% year-over-year; the trailing twelve-month figure through Dec 2025 was $964.0 million (up 157.75% YoY), and the FY2025 annual result was $964.0 million, up 157.75% from the prior year.
• Change in Acquisitions & Divestments was $132.0 million for Q4 2025 at Eli Lilly, down from $556.1 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $753.4 million in Q4 2021 and troughed at -$172.3 million in Q2 2023.
• Average Change in Acquisitions & Divestments over 5 years is $149.4 million, with a median of $69.2 million recorded in 2024.
• Year-over-year, Change in Acquisitions & Divestments soared 6811.93% in 2021 and plunged 657.61% in 2023.
• Over 5 years, Change in Acquisitions & Divestments stood at $753.4 million in 2021, then tumbled by 65.61% to $259.1 million in 2022, then jumped by 36.16% to $352.8 million in 2023, then sank by 84.13% to $56.0 million in 2024, then surged by 135.71% to $132.0 million in 2025.
• Per Business Quant data, the three most recent Change in Acquisitions & Divestments figures were $132.0 million in Q4 2025, $556.1 million in Q3 2025, and $204.3 million in Q2 2025.